MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

MDT

97.17

+2.33%↑

VEEV

295.69

+0.08%↑

A

141.95

+2.63%↑

HQY

90.19

-0.24%↓

PHR.US

23.94

+5.88%↑

Search

Pacira Pharmaceuticals Inc-DE

Deschisă

SectorSănătate

24.74 0.69

Rezumat

Modificarea prețului

24h

Curent

Minim

24.43

Maxim

25.25

Indicatori cheie

By Trading Economics

Venit

-9.7M

-4.8M

Vânzări

12M

181M

Marjă de profit

-2.676

Angajați

788

EBITDA

-4.4M

29M

Recomandări

By TipRanks

Recomandări

Neutru

Prognoză pe 12 luni

+7.84% upside

Statistici piață

By TradingEconomics

Capitalizare de piață

76M

1.1B

Deschiderea anterioară

24.05

Închiderea anterioară

24.74

Sentimentul știrilor

By Acuity

50%

50%

149 / 371 Clasament în Healthcare

Scor tehnic

By Trading Central

Încredere

Very Strong Bearish Evidence

Pacira Pharmaceuticals Inc-DE Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

7 apr. 2025, 23:45 UTC

Acțiuni populare

Stocks to Watch: CVS Health, UnitedHealth Group, Spire Global, Pacira BioSciences

Comparație

Modificare preț

Pacira Pharmaceuticals Inc-DE Așteptări

Obiectiv de preț

By TipRanks

7.84% sus

Prognoză pe 12 luni

Medie 27.25 USD  7.84%

Maxim 30 USD

Minim 23 USD

În baza a 5 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruPacira Pharmaceuticals Inc-DE - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Neutru

5 ratings

2

Cumpărare

2

Păstrare

1

Vânzare

Scor tehnic

By Trading Central

24.83 / 26.38Suport & Rezistență

Termen scurt

Very Strong Bearish Evidence

Termen mediu

Strong Bullish Evidence

Termen lung

Weak Bullish Evidence

Sentiment

By Acuity

149 / 371 Clasament în Sănătate

Sentimentul știrilor

Neutral

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Pacira Pharmaceuticals Inc-DE

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid handheld cryoanalgesia device used to produce controlled doses of cold temperature to targeted nerves. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Tampa, Florida.
help-icon Live chat